Ronald H.W. Cooper

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ENGN

Current role

Board Member, CEO

2024-10-21–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	enGene Therapeutics Inc. (ENGN)	Chief Executive Officer and President	$700,000	—	—	$4,544,760	$483,000	$30,529	$5,758,289
2024	enGene Therapeutics Inc. (ENGN)	Chief Executive Officer and President	$196,951	—	—	$7,985,375	$246,960	$4,526	$8,433,812

No earnings-call appearances or filed executive changes recorded yet.